We are delighted to announce our participation in Rare Disease Day for another consecutive year. In addition to our internal activities, Medpace will be hosting a webinar on how advanced therapies are dramatically changing the way patients are treated for a wide variety of diseases – particularly for patients with rare diseases and orphan indications.
Read More
As part of Medpace’s ongoing partnership with the American Heart Association, we are delighted to once again announce our participation in the 2018 Heart Mini Marathon & Walk in downtown Cincinnati on Sunday, March 18th.
Read More
This year, Medpace marks its 25th year as a scientifically-driven, global full-service clinical research organization. A lot has changed in the past 25 years. What hasn’t changed is Medpace’s dedication to the mission of accelerating the global development of safe and effective medical therapeutics. In this post, we visually show how we’ve grown from a small group of dedicated people looking for a better way to conduct clinical research to a publicly held, global community of 2,500 employees across 35 countries.
Read More
Several weeks ago, we announced that Dr. Gregory Hale joined the Medpace medical leadership team. He is an experienced physician with clinical expertise in bone marrow transplantation, cellular therapies, and hematologic malignancies. We were eager to sit down with Dr. Hale to learn more about what attracted him to the Medpace model and what new innovations he is most excited about.
Read More
This July, Medpace will be celebrating 25 years of accelerating the global development of safe and effective medical therapeutics. Stop by Booth #1118 at DIA to celebrate with us.
Read More
Welcome to the Medpace blog! This space will be dedicated to addressing the most pressing and challenging topics that are currently facing the clinical development industry.
Read More